Pharmacodynamics Flashcards
PIP pathway
GTP-alpha turns on PLC which cleaves PIP2 into DAG and IP3. IP3 is water soluble and leads to increased Ca+2 release and contraction. DAG leads to PKC becoming active and phosphorylation which causes contraction and is the lipid soluble pathway
P glycoprotein role
- eliminate drugs from the brain
- reduce GI absorption
- excrete drugs in bile and urine
constitutive activity
occurs when concentration of receptors becomes very high (artificial expression/tumors)
cooperativity graph shape
dose-response curve has S shape
tachyphylaxis
decline in response when drug is applied acutely in repeated fashion
desensitization
receptor mediated, high doses of drugs applied continuously –> waning response
what desensitizes GCPRS
GRKs phosphorylate cytoplasmic tail, binds beta arrestin –> desensitization and internalization
3 determinants of drug movement across barriers
type of membrane, specialized transport mechanisms and physico-chemical property of drug
sinusoidal v. non sinusoidal capillary
non sinusoidal are continuous and have basement membranes, sinusoidal = discontinuous
2 active transport proteins
SLC (uptake, secondary) and ABC (efflux, primary)
2 types of ABC transporters
p-glycoprotein (MDR1), MRP1, important for ADE by pumping drugs out of cells, leads to cancer resistance by pumping out chemotherapeutic drugs
3 types of SLC transporters
SLC0, SLC22, SLC6
SLC transporters
no ATP used, do coupled transport using preexisting gradient
absorption efficiency relative to pKa
weak acids = high pKa, weak bases = low pKa
what has pharmaceutical equivalence
same active ingredient, identical in strength/concentration, dosage form, RoA